These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6164931)

  • 1. [Prospects and limitations of genetic engineering].
    Klingmüller W
    Naturwissenschaften; 1981 Mar; 68(3):120-7. PubMed ID: 6164931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant DNA technology.
    Emery AE
    Lancet; 1981 Dec 19-26; 2(8260-61):1406-9. PubMed ID: 6118771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of risk in genetic engineering research].
    Shivtsov OV
    Vestn Akad Med Nauk SSSR; 1981; (2):77-83. PubMed ID: 6941553
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic manipulation--potential medical and veterinary benefits.
    Br Vet J; 1980; 136(5):516-8. PubMed ID: 6164432
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for human gene therapy.
    Anderson WF
    Science; 1984 Oct; 226(4673):401-9. PubMed ID: 6093246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of genetically-engineered microbes in natural environments.
    Stotzky G; Babich H
    Recomb DNA Tech Bull; 1984 Dec; 7(4):163-88. PubMed ID: 6100330
    [No Abstract]   [Full Text] [Related]  

  • 7. [New knowledge and aspects in the use of biotechnology].
    Kolb E
    Z Gesamte Inn Med; 1986 May; 41(9):249-55. PubMed ID: 3460274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sir William Weipers commemorative lecture. The scientific and social impacts of recent advances in biotechnology.
    Henderson W
    Vet Rec; 1984 Aug; 115(6):118-20. PubMed ID: 6591625
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic manipulation advisory group (GMAG) and the environment for genetic engineering in Britain.
    Williamson R
    Biochem Soc Symp; 1979; 44():119-21. PubMed ID: 291433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ethical aspects of modern genetics].
    Lisker R
    Rev Invest Clin; 1990; 42(1):63-7. PubMed ID: 2236976
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary of "gene transfer into human somatic cells. State of the technology, medical risks, social and ethical problems: a report".
    Bayertz K; Paslack R; Schmidt KW
    Hum Gene Ther; 1994 Apr; 5(4):465-8. PubMed ID: 8049303
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosynthesis of proinsulin of carp (Cyprinus carpio) and characterization and cloning of mRNA.
    Rapoport TA; Prehn S; Tsamaloukas A; Coutelle C; Liebscher DH; Huth A; Rosenthal S
    Ann N Y Acad Sci; 1980; 343():111-32. PubMed ID: 6994550
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic manipulation: test-tube organisms.
    Greenaway P
    Nurs Mirror; 1980 Dec; 151(24):36-8. PubMed ID: 6449694
    [No Abstract]   [Full Text] [Related]  

  • 14. The promise and perils of synthetic biology.
    Tucker JB; Zilinskas RA
    New Atlantis; 2006; 12():25-45. PubMed ID: 16832953
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmid vectors for genetic manipulation in vitro.
    Sherratt DJ
    Biochem Soc Symp; 1979; 44():29-36. PubMed ID: 387037
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of safety in biotechnology. Products of genetic engineering and regulation of work with them].
    Vorob'ev AA; Chugasova VA; Korovkin VI
    Mol Gen Mikrobiol Virusol; 1987 Sep; (9):3-10. PubMed ID: 3323899
    [No Abstract]   [Full Text] [Related]  

  • 17. Restricting the dispersal of recombinant DNA: design of a contained biological catalyst.
    Munthal MT; Timmis KN; Díaz E
    Biotechnology (N Y); 1996 Feb; 14(2):189-91. PubMed ID: 9636322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnology report urges 10 million pound programme "to match competitors".
    Walgate R
    Nature; 1980 Jan; 283(5745):324-5. PubMed ID: 6928053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recombinant strains: their biological properties and the safety measures in working with them].
    Vorob'ev AA; Khoroshko NV; Selezneva OIu
    Vestn Ross Akad Med Nauk; 1993; (2):31-7. PubMed ID: 7688617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containment.
    Levine MM; Kaper JB; Lockman H; Black RE; Clements ML; Falkow S
    Recomb DNA Tech Bull; 1983 Sep; 6(3):89-97. PubMed ID: 6314442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.